Weekly Influenza and Acute Respiratory Infection Report

	Current level of activity	Trend	News
Influenza	Medium levels	Increasing	The flu season is likely at peak levels. Influenza A(H1) accounts for the highest proportion of confirmed cases, with lower-level co-circulation of influenza A(H3) and influenza B.
RSV	Low intensity levels	Decreasing	The RSV season has peaked and is now decreasing, with activity in children now at ‘low’ intensity.
COVID-19	*	Stable	Broadly stable and at lower levels than previously.

* Comparative thresholds for COVID-19 intensity are not yet available

For the latest annual influenza and acute respiratory infections in Wales reports see: Annual influenza surveillance and influenza vaccination uptake reports

Weekly Integrated respiratory infection report

As of 2024 Week 40, the Public Health Wales Weekly Integrated respiratory infection report replaces previously separate outputs on COVID-19 surveillance and influenza surveillance. The current week's report is available here:

Public: Weekly acute respiratory infection summary: Week 02 2025

Internal NHS users: Weekly acute respiratory infection summary: Week 02 2025

Latest vaccination coverage data: Public Health Wales Influenza Vaccination Coverage Downloadable Data

Key points

In Wales:

Flu activity surveillance update

The GP consultation rate for influenza in Wales during week 02, 2025 reported through the GP Sentinel Surveillance of Infections Scheme was 39.7 consultations per 100,000 practice population.
The rate increased compared to week 01, 2025 (36.2 consultations per 100,000).

Virological surveillance update

A total of 473 surveillance samples were collected from patients presenting with ILI symptoms by sentinel GPs and community pharmacies during Week 02. Among these, the following pathogens were identified: 97 cases of influenza A, 41 cases of rhinovirus, 20 cases of RSV, 15 cases of coronaviruses, 11 cases of adenovirus, nine cases of influenza B, eight cases of parainfluenza, six cases of C.pneumoniae, five cases of enterovirus, five cases of SARS-CoV-2 (COVID-19), and three cases of Mycoplasma pneumoniae. Data are current as of 15/07/2025
During week 02, 1,425 hospital and non-sentinel GP patient samples underwent full respiratory screen multiplex testing by Public Health Wales Microbiology, of which, 276 were positive for influenza. A number of other causes of acute respiratory infection were identified (see full report). These tests are usually prioritised for symptomatic patients in hospitals, or less commonly community settings.
Confirmed RSV case incidence in children aged under 5 decreased and is now at low intensity levels.

Hospitalisations in confirmed cases of influenza and RSV

The 7-day rolling sums of cases hospitalised within 28 days of an influenza, RSV or SARS-CoV-2 positive test result in the community (or up to two days post-admission) were 216, 53 and 26 respectively for during week 02.
For further information see the Public Health Wales Dashboard on hospital admissions in ARI cases

In the UK and Europe

As of Week 01, GP ILI consultations increased to 20.6 per 100,000 in England and increased in Northern Ireland to 38.5 per 100,000. As of Week 01 GP ILI consultations increased to 33.0 per 100,000 in Scotland UKHSA Influenza and COVID-19 Surveillance Report.
The WHO and the European Respiratory Virus Surveillance Summary (ERVISS) reported that influenza positivity is above the 10% positivity epidemic threshold.
For more information on European level influenza surveillance see European Respiratory Virus Surveillance Summary (ERVISS)

World Overview

The WHO reported on 08/01/2024, based on data up to 29/12/2024 that in the Northern hemisphere influenza activity was elevated. Increased activity was observed in many countries in Europe (mostly A(H1N1)pdm09 detected, with A(H3N2) and B viruses also detected), Central America and the Caribbean (mostly A(H3N2)), Western Africa (co-circulation of influenza viruses), Middle Africa (mostly A(H1N1)pdm09), Northern Africa (mostly A(H3N2)), and many countries in Asia (mostly A(H1N1)pdm09 detected, with B viruses co-circulating in Western Asia).
In the Southern hemisphere, influenza activity was elevated in countries in Tropical South America (mostly B viruses detected) and elevated and increasing in Eastern Africa (mostly B viruses) and Melanesia (mostly A(H1N1)pdm09). See full WHO influenza update

COVID-19

Latest COVID-19 data from Public Health Wales
Latest UK data is available from: UK GOV: Coronavirus Data
WHO situation updates on COVID-19 are available from: WHO situation updates are available here

MERS-CoV and H7N9 Updates

WHO was notified of one new MERS cases on 5 September 2024 by the Ministry of Health of the Kingdom of Saudi Arabia.
The WHO has published an updated assessment of recent influenza A(H5N1) virus events in animals and people. Currently, the global public health risk of influenza A(H5N1) viruses to be low, while the risk of infection for occupationally exposed persons is low to moderate, depending on the risk mitigation measures in place. Transmission between animals continues to occur and, to date, a limited number of human infections have been reported.
Updates are available from WHO Global Alert and Response
Latest WHO Influenza Monthly Risk Assessment Summary
Public Health Wales has published advice to health professionals which is available at MERS-CoV and Influenza H7N9 infection control preparedness